Lv3
348 积分 2025-03-07 加入
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway
2小时前
待确认
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
2小时前
已完结
Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses
2个月前
已完结
CASQ2 alleviates lung cancer by inhibiting M2 tumor‐associated macrophage polarization and JAK/STAT pathway
2个月前
已完结
The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis
2个月前
已完结
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
2个月前
已完结
All-trans retinoic acid beyond acute promyelocytic leukemia
3个月前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
4个月前
已完结
An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma
4个月前
已完结
Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy
4个月前
已完结
皖公网安备34019202002308
